Alkermes plc EBITDA
Was ist das EBITDA von Alkermes plc?
EBITDA von Alkermes plc ist $394.679M
Was ist die Definition von EBITDA?
Das EBITDA ist das Ergebnis eines Unternehmens vor Zinsen, Steuern, Abschreibungen und Amortisationen und ist eine Buchhaltungsgröße, die anhand des Nettoergebnisses eines Unternehmens berechnet wird, bevor Zinsaufwendungen, Steuern, Abschreibungen und Amortisationen abgezogen werden, um die derzeitige operative Ertragskraft eines Unternehmens zu ermitteln.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Alkermes plc
Was macht Alkermes plc?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Unternehmen mit ebitda ähnlich Alkermes plc
- Damodar Industries hat EBITDA von ₨392.384M
- Chinney Investments hat EBITDA von HKD$393.365M
- Derichebourg SA hat EBITDA von €393.500M
- Asahi Songwon Colors hat EBITDA von ₨393.596M
- Shanghai Medicilon hat EBITDA von ¥394.231M
- Gran Tierra Inc hat EBITDA von $394.425M
- Alkermes plc hat EBITDA von $394.679M
- Mukand hat EBITDA von ₨394.950M
- Perfect Shape Beauty Technology hat EBITDA von HKD$395.002M
- At Home Inc hat EBITDA von $395.265M
- Spin Master hat EBITDA von $395.300M
- Arcos Dorados Inc hat EBITDA von $395.380M
- EPR Properties hat EBITDA von $395.493M